Supernus Pharmaceuticals, Inc. (SUPN)
41.92
+0.08
(+0.19%)
USD |
NASDAQ |
Oct 30, 16:00
41.92
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Cash and Short Term Investments (Annual) : 308.67M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 308.67M |
| December 31, 2024 | 453.61M |
| December 31, 2023 | 254.87M |
| December 31, 2022 | 461.33M |
| December 31, 2021 | 339.68M |
| December 31, 2020 | 422.53M |
| December 31, 2019 | 347.07M |
| December 31, 2018 | 356.02M |
| December 31, 2017 | 140.04M |
| Date | Value |
|---|---|
| December 31, 2016 | 90.12M |
| December 31, 2015 | 62.19M |
| December 31, 2014 | 74.34M |
| December 31, 2013 | 82.19M |
| December 31, 2012 | 88.79M |
| December 31, 2011 | 94.25M |
| December 31, 2010 | 32.96M |
| December 31, 2009 | 68.60M |
| December 31, 2008 | 66.66M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | 195.00M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Prestige Consumer Healthcare, Inc. | 63.87M |
| Bristol Myers Squibb Co. | 10.67B |
| Liquidia Corp. | 190.68M |